AVITA Medical, Inc. (RCEL)

NASDAQ: RCEL · Real-Time Price · USD

5.03

-0.08 (-1.57%)

At close: Feb 27, 2026, 4:00 PM EST

5.07

+0.04 (0.80%)

After-hours: Feb 27, 2026, 4:17 PM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
Recell Devices	71.61M	64.25M	50.14M	34.42M	33.03M
Recell Devices Growth	11.45%	28.14%	45.68%	4.23%	12.98%
Total	71.61M	64.25M	50.14M	34.42M	33.03M
Total Growth	11.45%	28.14%	45.68%	4.23%	12.98%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020	Jun '19 Jun 30, 2019	Jun '18 Jun 30, 2018	Jun '17 Jun 30, 2017
United States	68.79M	62.16M	46.36M	33.26M	32.73M
United States Growth	10.67%	34.08%	39.40%	1.61%	13.03%
Japan	2.09M	1.43M	3.37M	729.00K	-
Japan Growth	45.91%	-57.54%	362.28%	-	-
European Union	49.00K	155.00K	51.00K	-	-
European Union Growth	-68.39%	203.92%	-	-	-
Australia	200.00K	312.00K	222.00K	275.00K	210.00K
Australia Growth	-35.90%	40.54%	-19.27%	30.95%	1.45%
United Kingdom	486.00K	196.00K	141.00K	160.00K	86.00K
United Kingdom Growth	147.96%	39.01%	-11.88%	86.05%	22.86%
Total	71.61M	64.25M	50.14M	34.42M	33.03M
Total Growth	11.45%	28.14%	45.68%	4.23%	12.98%

Source: S&P Global Market Intelligence.